Cargando…

Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron

Desferrioxamine (DFO) is a bacterial siderophore with a high affinity for iron, but low cell penetration. As part of our ongoing project focused on DFO-conjugates, we synthesized, purified, characterized and studied new mtDFOs (DFO conjugated to the Mitochondria Penetrating Peptides TAT(49-57), 1A,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alta, Roxana Y. P., Vitorino, Hector A., Goswami, Dibakar, Liria, Cleber W., Wisnovsky, Simon P., Kelley, Shana O., Machini, M. Terêsa, Espósito, Breno P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298241/ https://www.ncbi.nlm.nih.gov/pubmed/28178347 http://dx.doi.org/10.1371/journal.pone.0171729

Ejemplares similares

The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG
por: Cahill, Christina, et al.
Publicado: (2021)

Impact of labile plasma iron and iron chelation on the viability of cultured mononuclear cells from patients undergoing autologous hematopoietic stem cell transplantation
por: Naoum, Flávio Augusto, et al.
Publicado: (2017)

Iron-chelating agent desferrioxamine stimulates formation of neutrophil extracellular traps (NETs) in human blood-derived neutrophils
por: Völlger, Lena, et al.
Publicado: (2016)

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
por: Perk, Lars R., et al.
Publicado: (2009)

Re-Directing an Alkylating Agent to Mitochondria Alters Drug Target and Cell Death Mechanism
por: Mourtada, Rida, et al.
Publicado: (2013)

Desferrioxamine Reduces Oxidative Stress in the Lung Contusion
por: Basaran, Umit Nusret, et al.
Publicado: (2013)

Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
por: Pepe, Alessia, et al.
Publicado: (2011)

Hydroxytyrosol inhibits hydrogen peroxide-induced apoptotic signaling via labile iron chelation
por: Kitsati, Natalia, et al.
Publicado: (2016)

Desferrioxamine decreases NAD redox potential of intact red blood cells: evidence for desferrioxamine as an inducer of oxidant stress in red blood cells
por: Niihara, Yutaka, et al.
Publicado: (2002)

Desferrioxamine-related ocular toxicity: A case report
por: Simon, Sumu, et al.
Publicado: (2012)

Tales of the Unexpected: The Case of Zirconium(IV) Complexes with Desferrioxamine
por: Savastano, Matteo, et al.
Publicado: (2019)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
por: Pepe, Alessia, et al.
Publicado: (2011)

Fast Ion-Chelate Dissociation Rate for In Vivo MRI of Labile Zinc with Frequency-Specific Encodability
por: Tirukoti, Nishanth D., et al.
Publicado: (2021)

Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
por: Kaeppeli, Simon A. M., et al.
Publicado: (2019)

(68)Ga-labelled desferrioxamine-B for bacterial infection imaging
por: Petrik, Milos, et al.
Publicado: (2020)

Design of a water-soluble chitosan-based polymer with antioxidant and chelating properties for labile iron extraction
por: Grange, Coralie, et al.
Publicado: (2023)

DNA Polymerase θ Increases Mutational Rates in Mitochondrial DNA
por: Wisnovsky, Simon, et al.
Publicado: (2018)

Desferrioxamine Supports Metabolic Function in Primary Human Macrophages Infected With Mycobacterium tuberculosis
por: Phelan, James Joseph, et al.
Publicado: (2020)

Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease
por: Francisco, Amanda Fortes, et al.
Publicado: (2013)

Phosphorylation of SMC1 by ATR is required for desferrioxamine (DFO)-induced apoptosis
por: So, E Y, et al.
Publicado: (2011)

Pulmonary effects of desferrioxamine in the treatment of an experimental model of fulminant hepatic failure
por: Kalimeris, K, et al.
Publicado: (2007)

Synergistic protection of bone vasculature and bone mass by desferrioxamine in osteoporotic mice
por: Wang, Liang, et al.
Publicado: (2017)

Performance of Redox Active and Chelatable Iron Assays to Determine Labile Iron Release From Intravenous Iron Formulations
por: Pai, AB, et al.
Publicado: (2017)

Efficacy of desferrioxamine mesylate in intracerebral hematoma: a systemic review and meta-analysis
por: Zhao, Kai, et al.
Publicado: (2022)

Chemoenzymatic Synthesis of Select Intermediates and Natural Products of the Desferrioxamine E Siderophore Pathway
por: Hoffmann, Katherine M., et al.
Publicado: (2022)

Radiochemistry and Preclinical PET Imaging of (68)Ga-Desferrioxamine Radiotracers Targeting Prostate-Specific Membrane Antigen
por: Gourni, Eleni, et al.
Publicado: (2017)

A genome-wide analysis of desferrioxamine mediated iron uptake in Erwinia spp. reveals genes exclusive of the Rosaceae infecting strains
por: Polsinelli, Ivan, et al.
Publicado: (2019)

Evaluation of zoledronate, cytochalasin-D, and desferrioxamine on osseointegration in an intra-medullary femoral implant model
por: Leatherwood, William H., et al.
Publicado: (2020)

Desferrioxamine-Related Pseudo-Vitelliform Dystrophy and the Effect of Anti-Vascular Endothelial Growth Factor
por: Grinton, Michael E., et al.
Publicado: (2021)

Fluorescent and Photosensitizing Conjugates of Cell-Penetrating Peptide TAT(47-57): Design, Microwave-Assisted Synthesis at 60 °C, and Properties
por: Okuda-Shinagawa, Nancy M., et al.
Publicado: (2017)

An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use
por: Ward, Alexandra, et al.
Publicado: (2002)

The desferrioxamine-prochlorperazine coma—clue to the role of dopamine-iron recycling in the synthesis of hydrogen peroxide in the brain
por: Smythies, John, et al.
Publicado: (2014)

Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer
por: de Souza, Ana Luiza Ribeiro, et al.
Publicado: (2016)

Desferrioxamine B-Mediated Pre-Clinical In Vivo Imaging of Infection by the Mold Fungus Aspergillus fumigatus
por: Misslinger, Matthias, et al.
Publicado: (2021)

Bibliometric Review on New Possibilities of Antimycobacterial Agents: Exploring Siderophore Desferrioxamine’s Applications as an Antimicrobial Agent
por: de Oliveira, Patrícia Vieira, et al.
Publicado: (2023)

Penetrating Cations Enhance Uncoupling Activity of Anionic Protonophores in Mitochondria
por: Antonenko, Yuri N., et al.
Publicado: (2013)

Alkali-labile gangliosides
por: Mauri, Laura, et al.
Publicado: (2023)

MSFragger-Labile: A Flexible Method to Improve Labile PTM Analysis in Proteomics
por: Polasky, Daniel A., et al.
Publicado: (2023)

Liposomes containing chelating agents. Cellular penetration and a possible mechanism of metal removal
Publicado: (1975)

Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B
por: Ma, Michelle T., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s2abaiu61sh0uubf37qc1id8uv